BioSyent Pharma, a subsidiary of BioSyent, has signed an exclusive licensing and distribution agreement with an undisclosed European partner for two new products, which will be marketed by its' Hospital Products Division.

The two products use a patented delivery system, which will provide Canadian hospitals and healthcare professionals safety and cost effectiveness, according to the company.

The products will be launched after receiving approval from Health Canada.

BioSyent Pharma sources and acquires or in-licences pharmaceutical products and markets them in Canada.